Form 483

Hemagen Diagnostics Inc Form 483, 2026-05-14

FDA issued a Form 483 to Hemagen Diagnostics Inc on 2026-05-14 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Hemagen Diagnostics Inc · Baltimore, United States · Issued May 14, 2026

Overview

  • 6 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 May 2026
ISO 13485:2016 Clause 4.2.5

Procedures for control of records not documented

Cited by Christina D Mello

14 May 2026
ISO 13485:2016 Clause 7.4.1

Supplier performance not monitored

Cited by Christina D Mello

14 May 2026
ISO 13485:2016 Clause 8.5.2

Corrective action not taken

Cited by Christina D Mello

14 May 2026
ISO 13485:2016 Clause 8.5.2

Corrective action procedures not documented

Cited by Christina D Mello

14 May 2026
ISO 13485:2016 Clause 8.5.2

Corrective action not taken

Cited by Christina D Mello

Inspected site

HDHemagen Diagnostics IncBaltimore, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
ISO 13485:2016 Clause 8.5.2Cited across public-safe Form 483 observations4x
ISO 13485:2016 Clause 4.2.5Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.4.1Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere